These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6410103)

  • 1. [Outcome and future of mass screening for uterine cervical cancer].
    Noda K; Tejima K
    Gan No Rinsho; 1983 May; 29(6):483-7. PubMed ID: 6410103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The present status of mass population screening for cancer of the uterine cervix and the therapeutic results in the detected cases in Miyagi Prefecture].
    Sato S; Toki T; Yamauchi R; Wakisaka T; Sakahira H; Mori T; Yajima A; Suzuki M; Nasu I; Sato S; Kaneda N; Higashiiwai H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Feb; 35(2):127-33. PubMed ID: 6864010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Costs and effects of alternative screening programs against cervical cancer].
    Gyrd-Hansen D; Hølund B; Andersen P
    Ugeskr Laeger; 1996 Aug; 158(35):4912-5. PubMed ID: 8801698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of uterine cancer detected by mass screening].
    Igarashi T; Konno R; Sato S; Yajima A
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1519-26. PubMed ID: 9725043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
    Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
    J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass screening program for cancer].
    Fujimoto I
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):727-32. PubMed ID: 6712270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
    Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
    Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-benefit analysis of the Program for Early Screening of Cervico-uterine Cancer].
    Hernández-Peña P; Lazcano-Ponce EC; Alonso-de Ruiz P; Cruz-Valdez A; Meneses-González F; Hernández-Avila M
    Salud Publica Mex; 1997; 39(4):379-87. PubMed ID: 9381251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
    Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
    Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for carcinoma of the cervix today].
    Calzolari E; Ciampaglia G; Coppola S
    Minerva Ginecol; 1996 Nov; 48(11):453-61. PubMed ID: 9005371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against HPV: indications for women and the impact on the cervical screening programme.
    Heideman DA; Snijders PJ; Berkhof J; Verheijen RH; Helmerhorst TJ; Meijer CJ
    BJOG; 2008 Jul; 115(8):938-46. PubMed ID: 18651878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of mass screening for uterine cancer].
    Kuzuya K; Ishikawa H
    Nihon Rinsho; 1996 May; 54(5):1441-6. PubMed ID: 8965382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
    Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.